Primary cutaneous B-cell lymphoma mimicking pyoderma gangrenosum: first-line treatment with rituximab.
Lami
M-C
MC
Vabres
P
P
Dreyfus
B
B
Germain
T
T
Guillet
G
G
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000175:diagnosis; D000069283:Rituximab; D012782:Shoulder; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab